Inverse Correlation Between Nesfatin-1 and Ghrelin O-Acyltransferase (GOAT) in Adolescents with Epilepsy: A Cross-Sectional Study
Biomolecules · 28.04.2026 · 16 (5) · 658
DOI: 10.3390/biom16050658 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Biomolecules, online erschienen am 28.04.2026. Verfasst von Anna Sojka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prosthodontics and Gerostomatology, Poznań University of Medical Sciences, 60-812 Poznań, Poland. Hauptthemen laut MEDLINE: Nucleobindins, Epilepsy, Acyltransferases, Nerve Tissue Proteins. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nesfatin-1 and ghrelin O-acyltransferase (GOAT) have established roles in metabolic regulation and neuronal excitability, yet their relationship in epilepsy remains conflicted. This cross-sectional study compared 22 adolescent epilepsy patients (13.1 ± 2.0 years; 11 women/11 men) with 20 age-matched healthy controls (HCs) (12.3 ± 2.2 years; 8 women/12 men). Serum and salivary nesfatin-1 and GOAT levels were measured by enzyme-linked immunosorbent assay; Spearman’s rank correlation assessed inter-neuropeptide relationships. Serum nesfatin-1 was markedly elevated in patients with epilepsy compared to HCs (44.04 (interquartile range 38.19–76.72) vs. 8.65 (interquartile range 7.82–9.01) ng/mL, p < 0.001; ~5-fold). Serum GOAT was similarly elevated (4.90 (interquartile range 4.17–6.66) vs. 1.41 (interquartile range 1.21–1.79) ng/mL, p < 0.001; 3.5-fold). A significant inverse correlation between serum nesfatin-1 and GOAT levels was identified in patients with epilepsy (rho = −0.68, 95% CI [−0.86, −0.36], p < 0.001) but not in HCs (p = 0.53) and remained independent of age, sex, body mass index and epilepsy type. This inverse correlation was significant in women (rho = −0.68, p = 0.021) with a similar trend in men (rho = −0.53, p = 0.096). Salivary nesfatin-1 mirrored serum patterns (2.3-fold increase; p < 0.001), while salivary GOAT showed a 9-fold reduction (p < 0.001). This study provides the first evidence of an inverse nesfatin-1/GOAT correlation in adolescent epilepsy, suggesting disease-specific neuroendocrine dysregulation. These exploratory findings support the potential of these neuropeptides as candidate biomarkers warranting further validation and offer new insights into the metabolic-excitability axis in epilepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Prosthodontics and Gerostomatology, Poznań University of Medical Sciences, 60-812 Poznań, Poland.
- Department of Developmental Neurology, Poznań University of Medical Sciences, 60-355 Poznań, Poland.
- Doctoral School, Poznań University of Medical Sciences, 60-812 Poznań, Poland.
ORCID-Profile: Ozgun Yetkin, Barbara Dorocka-Bobkowska, Marcin Zarowski
Zitieren
APA
Sojka, A., Yetkin, O., Bartosik, Y., Steinborn, B., Dorocka-Bobkowska, B., & Zarowski, M. (2026). Inverse Correlation Between Nesfatin-1 and Ghrelin O-Acyltransferase (GOAT) in Adolescents with Epilepsy: A Cross-Sectional Study. Biomolecules, 16(5), 658. https://doi.org/10.3390/biom16050658
Vancouver
Sojka A, Yetkin O, Bartosik Y, Steinborn B, Dorocka-Bobkowska B, Zarowski M. Inverse Correlation Between Nesfatin-1 and Ghrelin O-Acyltransferase (GOAT) in Adolescents with Epilepsy: A Cross-Sectional Study. Biomolecules. 2026;16(5):658. doi:10.3390/biom16050658
BibTeX
@article{Sojka2026,
author = {Sojka, Anna and Yetkin, Ozgun and Bartosik, Yasmin and Steinborn, Barbara and Dorocka-Bobkowska, Barbara and Zarowski, Marcin},
title = {Inverse Correlation Between Nesfatin-1 and Ghrelin O-Acyltransferase (GOAT) in Adolescents with Epilepsy: A Cross-Sectional Study},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {5},
pages = {658},
doi = {10.3390/biom16050658}
}
EUVIMED